JPS62215597A - Beta-mercapto-alpha-aminoethylphosphonic acid derivative - Google Patents
Beta-mercapto-alpha-aminoethylphosphonic acid derivativeInfo
- Publication number
- JPS62215597A JPS62215597A JP61056683A JP5668386A JPS62215597A JP S62215597 A JPS62215597 A JP S62215597A JP 61056683 A JP61056683 A JP 61056683A JP 5668386 A JP5668386 A JP 5668386A JP S62215597 A JPS62215597 A JP S62215597A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- amino
- formula
- mmol
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GQUPZJPZACSKNV-UHFFFAOYSA-N (1-amino-2-sulfanylethyl)phosphonic acid Chemical class SCC(N)P(O)(O)=O GQUPZJPZACSKNV-UHFFFAOYSA-N 0.000 title claims abstract description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 19
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 125000006239 protecting group Chemical group 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 239000002253 acid Substances 0.000 abstract description 51
- 150000001875 compounds Chemical class 0.000 abstract description 30
- 239000002904 solvent Substances 0.000 abstract description 22
- 239000007800 oxidant agent Substances 0.000 abstract description 5
- RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical compound OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003377 acid catalyst Substances 0.000 abstract description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 abstract description 2
- 150000001541 aziridines Chemical class 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 210000002421 cell wall Anatomy 0.000 abstract description 2
- 239000003112 inhibitor Substances 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 41
- -1 carbobenzoxy, p-methoxybenzyloxycarbonyl Chemical group 0.000 description 38
- 238000000034 method Methods 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000002844 melting Methods 0.000 description 16
- 230000008018 melting Effects 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000000354 decomposition reaction Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 238000010898 silica gel chromatography Methods 0.000 description 7
- VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 description 6
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229910052796 boron Inorganic materials 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000007142 ring opening reaction Methods 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DRUIESSIVFYOMK-UHFFFAOYSA-N Trichloroacetonitrile Chemical compound ClC(Cl)(Cl)C#N DRUIESSIVFYOMK-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- QQVDJLLNRSOCEL-UHFFFAOYSA-N (2-aminoethyl)phosphonic acid Chemical class [NH3+]CCP(O)([O-])=O QQVDJLLNRSOCEL-UHFFFAOYSA-N 0.000 description 1
- UIQSKEDQPSEGAU-UHFFFAOYSA-N 1-Aminoethylphosphonic Acid Chemical class CC(N)P(O)(O)=O UIQSKEDQPSEGAU-UHFFFAOYSA-N 0.000 description 1
- NKZAGWFPGZDKSN-UHFFFAOYSA-N 2-hydrazinylethylphosphonic acid Chemical class NNCCP(O)(O)=O NKZAGWFPGZDKSN-UHFFFAOYSA-N 0.000 description 1
- GAQAYJHBMKZXTQ-UHFFFAOYSA-N 2-methylsulfanylethylphosphonic acid Chemical compound CSCCP(O)(O)=O GAQAYJHBMKZXTQ-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000283986 Lepus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- WJGAPUXHSQQWQF-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O WJGAPUXHSQQWQF-UHFFFAOYSA-N 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 229940117953 phenylisothiocyanate Drugs 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
剤の合成中間体として有用なβ−メルカプ)−α−アミ
ノエチルホスホン酸誘導体に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to β-mercap)-α-aminoethylphosphonic acid derivatives useful as synthetic intermediates for pharmaceutical agents.
(発明の構成)
本発明の化合物は、下記一般式(1)で衣わされるβ−
メルカプト−α−アミノエチルホスホン酸誘導体に関す
る。(Structure of the Invention) The compound of the present invention is a β-
This invention relates to mercapto-α-aminoethylphosphonic acid derivatives.
HY
〔一般式(1)中nはo、i又は−を′X味し、Xはa
) l!を換基を有してもよいアルキル基(但しnが
OC7′)場合を含まない。)
を意味するか、又は
b)
Hs
(式中、Hsは水素原子又はアルキル基を意味する。)
を意味するか、又は
C)
R4NH−〇−
(式中、2は0又はS、R4は水素原子、アルキル基又
はアリール基を意味する。但しnが/および−の場合を
含まない。)を意味する。HY [In general formula (1), n represents o, i or -, and X represents a
) l! does not include the case where is an alkyl group which may have a substituent (however, n is OC7'). ), or b) Hs (in the formula, Hs means a hydrogen atom or an alkyl group), or C) R4NH-〇- (in the formula, 2 is 0 or S, R4 is means a hydrogen atom, an alkyl group, or an aryl group (excluding cases where n is / and -).
Yは水素原子又はアミノ基の保護基を、R1およびR2
は同一あるいは相異なる水素原子又はアルキル基を意味
する。〕
本発明のβ−wt撹アミノアミノエチルホスホン酸誘導
体て、一般式(1)のYが水素原子である化合物は、そ
れ目身細v14細胞壁の生合成阻害剤として価値がある
か゛、またYが7ミノ基の保!!!ll基である化合物
と共に、さらに価11I!する抗園性物Jx製造の合成
用中間体としてM用である、一般式(1)においてYが
アミノ基の保峡基であるときの保護基としてはペプチド
化学において常用される保り基、例えばカルボベンゾキ
シ、p−メトキシベンジルオキシカルボニル、tart
−ブトキシカルボニル又はトリチル等の基か好ましく採
用される。%R1およびR2のアルキル基としては炭素
数/乃至乙の直鎖又は分岐鎖のアルキルが挙けられる。Y is a hydrogen atom or a protecting group for an amino group, R1 and R2
means the same or different hydrogen atoms or alkyl groups. ] Among the β-wt stirred aminoaminoethylphosphonic acid derivatives of the present invention, compounds in which Y in the general formula (1) is a hydrogen atom are valuable as biosynthesis inhibitors of the slender V14 cell wall. is a 7-mino radical! ! ! With compounds that are ll groups, there is also a valence of 11I! When Y is a protective group of an amino group in the general formula (1), which is used as a synthetic intermediate for the production of an anti-inflammatory substance Jx, the protective group is a protective group commonly used in peptide chemistry, For example, carbobenzoxy, p-methoxybenzyloxycarbonyl, tart
Groups such as -butoxycarbonyl or trityl are preferably employed. Examples of the alkyl group for %R1 and R2 include straight-chain or branched alkyl having 1 to 2 carbon atoms.
Xがa)の場合、置換基を有してもよいアルキル基のア
ルキル基としては炭素数/乃至乙の直鎖又は分岐鎖のア
ルキルが挙げられる。置換基としてはアリール基例えば
フェニル基等、ヒドロキシ基、低級アルコキシ基、低級
アルカノイルオキシ基例えばアセトキシ基等、ベンゾイ
ルオキシ基、アミノ基、モノ又はジ低級アルキルアミノ
基、およびアシルアミノ基等が卒げられる。When X is a), examples of the alkyl group which may have a substituent include straight-chain or branched alkyl having a carbon number of 1 to 2. Examples of substituents include aryl groups such as phenyl groups, hydroxy groups, lower alkoxy groups, lower alkanoyloxy groups such as acetoxy groups, benzoyloxy groups, amino groups, mono- or di-lower alkylamino groups, and acylamino groups. .
【
の場合、R3のアルキル基としては炭素数/乃至乙の直
鎖又は分岐鎖のアルキルが挙げられる。In the case of [ , the alkyl group for R3 includes a straight or branched alkyl having a carbon number of 1 to 2.
Xがc) Z
R4NkI−0−
の賜金、R’のアルキル基としては炭素数に乃至乙の直
鎮又は分岐鎖のアルキルが、アリール基トシテはフェニ
ル、ナフチル、ビフェニリルおよびテトラヒドロナフチ
ル叫が挙けられる。Where X is c) Z R4NkI-0-, the alkyl group of R' is a straight or branched alkyl having a carbon number of up to 1, and the aryl group is phenyl, naphthyl, biphenylyl and tetrahydronaphthyl. It will be done.
本発明の一般式(1)で示されるβ−メルカプト−α−
アミノエチルホスホン酸誘導体において、Y、R1およ
びR2が水素原子である場合、これらの基はそのままの
形であってもよりが、更に他のd6るいは塩基と塩を形
成してもよい。β-mercapto-α- represented by general formula (1) of the present invention
In the aminoethylphosphonic acid derivative, when Y, R1 and R2 are hydrogen atoms, these groups may be used as they are or may form a salt with another d6 or a base.
この碌な塩としては、アミンの塩はfji酸、具化水素
および硫酸等の鉱酸による塩、若しくは有機酸による塩
、ホスホン酸の塩としては、ナトリウム、カリウム、カ
ルシウム又はマグネシウム等のアルカリおよびアルカリ
土類金属によるア
塩、アンモニブ若しくはイ弓゛磯アミン等による7価あ
るAは一価の埴か挙けられる。These strong salts include amine salts, salts with mineral acids such as fjiic acid, hydrogen oxide, and sulfuric acid, or salts with organic acids; salts of phosphonic acids include alkali salts such as sodium, potassium, calcium, or magnesium; The heptavalent A salts of alkaline earth metals, ammonibs, and amines are monovalent.
本発明のβ−メルカプト−α−アミノエチルホスホン酸
誘導体の具体的な例として以下の化合物が挙けられる。Specific examples of the β-mercapto-α-aminoethylphosphonic acid derivatives of the present invention include the following compounds.
7!/−カルボペンゾキシアミノ−コーメチルチオエチ
ルホスホン111B−オキシド二 /−アミノーコーメ
チルチオエチルホスホン酸S−オキシド
3 /−カルボベンゾキシアミノ−2−エチルチオエチ
ルホスホン藪S−オキシド
ペ /−アミノーーーエチルチオエチルホスホン酸S−
オキシド
よ /−アミノ−コーメチルチオエチルホスホンrIR
B−ジオキシド
K /−アミノーーーエチルチオエチルホスホン酸S−
ジオキシド
Z /−カルポペンゾキシアミノーーーメチルチオエチ
ルホワホン鹸モノエチルエステルよ /−アミノーコー
メチルチオエチルホスホン酸モノエチルエステル
9 /−力ルポペンゾキシアミノーコーエチルチオエチ
ルホスホン酸モノエチルエステル10 /−アミノ−
2−エチルチオエチルホスホン酸モノエチルエステル
///−アミノーーーメチルチオエチルホスホン酸モノ
エチルエステル日−ジオキシド/2 /−アミノ−λ−
エチルチオエチルホスホン酸モノエチルエステルS−ジ
オキシド73 /−アミノ−λ−(/′−メチルテトラ
ゾールー!′−イル)チオエチルホスホン酸ジエチルエ
ステル
/偵/−アミノーコー(/′−メチルテトラゾールー!
′−イル)チオエチルホスホン酸/ヨ/−カルボベンゾ
キシアミノ−2−(/’−メチルテトラゾールー5′−
イル)チオエチルホスホン酸
/へ/−カルボベンゾキシアミノーコー(//−メチル
テトラゾール−t′−イル)チオエチルホスホン酸モノ
エチルエステル
/7 /−アミノ−(/′−メチルテトラゾールー!
′−イル)チオエチルホスホン酸モノエチルエステル
/よ /−アミノーコーカルバモイルチオエチルホスホ
ン戯
79 /−アミノーコーフェニル力ルバモイルテオエチ
ルホスホン飯・塩澱塩
2θ /−アミノ−λ−フェニルチオカルバモイルチオ
エチルホスホン醗
21 /−カルポベンゾキシアミノーーー(−l。7! /-carbobenzoxyamino-comethylthioethylphosphone 111B-oxide 2 /-amino-comethylthioethylphosphonic acid S-oxide 3 /-carbobenzoxyamino-2-ethylthioethylphosphone Yabu S-oxidope /-amino- -Ethylthioethylphosphonic acid S-
Oxide /-amino-comethylthioethylphosphone rIR
B-dioxide K /-amino-ethylthioethylphosphonic acid S-
Dioxide Z /-carpopenzoxyamino--methylthioethyl monoethyl ester /-amino-comethylthioethylphosphonic acid monoethyl ester 9 /-carpopenzoxyamino-coethylthioethylphosphonate monoethyl ester Ester 10 /-amino-
2-Ethylthioethylphosphonic acid monoethyl ester///-amino--methylthioethylphosphonic acid monoethyl ester/dioxide/2/-amino-λ-
Ethylthioethylphosphonic acid monoethyl ester S-dioxide 73 /-amino-λ-(/'-methyltetrazol-!'-yl)thioethylphosphonic acid diethyl ester/-amino-cor(/'-methyltetrazol-!'-yl)
'-yl)thioethylphosphonic acid/yo/-carbobenzoxyamino-2-(/'-methyltetrazole-5'-
yl)thioethylphosphonic acid/h/-carbobenzoxyaminocor(//-methyltetrazol-t'-yl)thioethylphosphonic acid monoethyl ester/7/-amino-(/'-methyltetrazole-!
'-yl)thioethylphosphonic acid monoethyl ester /-amino-cocarbamoylthioethylphosphonic acid 79 /-amino-co-phenylated rubbermoyl-thioethyl phosphonic acid salt starch salt 2θ /-amino-λ-phenylthio Carbamoylthioethylphosphone 21 /-carpobenzoxyamino (-l.
3′−ジヒドロキシグロビル)チオエチルホスホン酸ジ
エチルエステル
2二 /−アミノーーー(λ′、3′−ジヒドロキシプ
ロピル)チオエチルホスホン酸
次に、本発明の化合物の代表的な製造法を述べる事によ
シ本発明な更に詳細に説明するが、これはあくまでも代
表的な製造法であって、これに限定されるものではない
。3'-dihydroxyglobil)thioethylphosphonic acid diethyl ester 22/-amino-(λ',3'-dihydroxypropyl)thioethylphosphonic acid Next, a representative method for preparing the compounds of the present invention will be described. The present invention will be explained in more detail, but this is only a typical manufacturing method and is not limited thereto.
本発明のβ−メルカプト−α−アミノエチルホスホン酸
誘専体の代表的な製造法として次のA乃至E法が挙げら
れる。The following methods A to E are listed as typical methods for producing the β-mercapto-α-aminoethylphosphonic acid derivative of the present invention.
A法
(I) (Ill) (IV)(式
中、K、 Y、 R’ オヨU R2+! 一般式(1
) f)それと同じ意味を有する。但しR1およびR2
が水素原子、Xがd)である場合を含まない。)すなわ
ち一般式(I[)で示されるアジリジン誘導体を酸触媒
の存在下、適幽な溶媒中、一般式(1)で示されるメル
カプタン類にょシ開環反応させ一般式(IV)で示され
る目的のβ−メルヵグトーα−アミノエチルホスホン酸
誘尋体を製造する方法である。Method A (I) (Ill) (IV) (where K, Y, R' Oyo U R2+! General formula (1
) f) have the same meaning. However, R1 and R2
does not include the case where is a hydrogen atom and X is d). ) That is, an aziridine derivative represented by the general formula (I[) is subjected to a ring-opening reaction with a mercaptan represented by the general formula (1) in a suitable solvent in the presence of an acid catalyst to form a ring-opening reaction represented by the general formula (IV). This is a method for producing the desired β-mercagto α-aminoethylphosphonic acid derivative.
2−アシリジンホスホン酸類の開環反応は通常酸触媒と
して塩酸又は硫酸を使用し実施される[ J、Zygm
unt、 P、 Mastalerz、 Po1ish
J。The ring-opening reaction of 2-acylidinephosphonic acids is usually carried out using hydrochloric acid or sulfuric acid as an acid catalyst [J, Zygm
unt, P, Mastalerz, Polish
J.
Ohem 12 2λ7/(/97/)、66 ’I
I/(/りl/)〕が更により方法は触媒としてBP、
−ジエチルエーテル錯体を使用し、非水浴妹で行う方法
である、触媒としてBIF、−ジエチルエーテル錯体を
使用する場合を例示すると、浴媒として例えばクロロホ
ルム又はジクロロメタンを使用し、室温において円滑、
容易且つ高収率に反応は実施される。本反応は通常、一
般式(11)のYが保護基の形で実励されるが、一般式
(1■)で示されるX−8Rの求核性が大きい場合Yが
水素原子の場合でも好都合に実施される。Ohem 12 2λ7/(/97/), 66 'I
BP as a catalyst,
An example of a method using a diethyl ether complex and BIF as a catalyst in a non-water bath is to use, for example, chloroform or dichloromethane as a bath medium, and to perform the process smoothly at room temperature.
The reaction is carried out easily and in high yield. This reaction is usually carried out with Y in general formula (11) in the form of a protecting group, but if the nucleophilicity of X-8R shown in general formula (1) is large, even when Y is a hydrogen atom, conveniently carried out.
B法
O
HY
(V) C’v1)
(■)
(式中、Y、2%部、R1およびR4は一般式(1)の
それと同じ意味を有す。)
すなわち一般式(V)で示される化合物と一般式(Vl
)で示されるβ−メルカプト−α−7ミノエチルホスホ
ン酸類を適当なIv媒中付加反応させ一般式(■)で示
される目的の化合物を製造する方法である。Method B O HY (V) C'v1) (■) (In the formula, Y, 2% part, R1 and R4 have the same meanings as in general formula (1).) That is, represented by general formula (V) The compound and general formula (Vl
) is a method for producing the target compound represented by the general formula (■) by carrying out an addition reaction of β-mercapto-α-7minoethylphosphonic acids represented by the following in an appropriate IV medium.
この反応は、公知の方法例えばシスティン類における当
該付加反応を応用し実施される。This reaction is carried out by applying a known method, for example, the addition reaction of cysteines.
[L、 0.8m1th、 J、 S、Humphre
ys、 O,G。[L, 0.8m1th, J, S, Humphre
ys, O, G.
akinner、 W、8hive、 Teras R
epts、 Biol、 Med。akinner, W, 8hive, Teras R
epts, Biol, Med.
2/ (2) −タロ(/り63)、 D、L、R
a5s、C,G。2/ (2) - Taro (/ri63), D, L, R
a5s, C, G.
□ 。□ .
akinner、W、5hive、J6Med、and
Pharm。akinner, W, 5hive, J6Med, and
Pharm.
Chem、j !/9 (/タイ/)、 JoM、Ra
ven、T、J。Chem, j! /9 (/Thailand/), JoM, Ra
ven, T.J.
McOord O,G 8に4nner、W、8hiv
e 、T、Biol。McOord O, G 8 to 4nner, W, 8hiv
e, T, Biol.
Ohem、、2J、2 /69 (/り!/)〕。Ohem,, 2J, 2 /69 (/ri!/)].
c法
N)i Y kNI Y(IV)
(■〕
(式中、K、Y、R1およびit”は一般式(1)のそ
れと陶じ意味を有す)
すなわち一般式(1v)で示されるβ−メルカプト−α
−7ミノエチルホスホンuR誘専体を適当な溶媒中、酸
化剤で酸化し一般式(m)で示されル目的のスルホキシ
ド体を製造する方法である。c method N)i Y kNI Y(IV)
(■) (In the formula, K, Y, R1 and it" have the same meanings as in general formula (1)) That is, β-mercapto-α represented by general formula (1v)
This is a method for producing the desired sulfoxide compound represented by the general formula (m) by oxidizing -7 minoethylphosphone uR derivative with an oxidizing agent in a suitable solvent.
この反応はスルフィド体を酸化してスルホキシド体を製
造する公知の方法を応用し実施される。代表的な製造法
は酸化剤として過ヨウ素酸ナトリウムを使用し、水性溶
媒中で行う方法である〔0.R,Johnson、 J
、 Ilf、 Keiser、 OrganicEly
nthesia OoloMol v、Pフタ/
John Wiley &5ons、New York
(/り74t))。This reaction is carried out by applying a known method for producing a sulfoxide compound by oxidizing a sulfide compound. A typical manufacturing method uses sodium periodate as an oxidizing agent and is carried out in an aqueous solvent [0. R, Johnson, J.
, Ilf, Keiser, OrganicEly
nthesia OoloMol v, P lid/
John Wiley & 5ons, New York
(/ri74t)).
D法
(バ) (■)(式中、X、
Y、R’ おjびR” バ一般式(1) +7)そねと
同じ意味を有する。)
すなわち、一般式(IV)で示されるβ−ツルカプト−
α−7ミノエチルホスホン酸肪導体を適当な溶媒中、酸
化剤で酸化し一般式(V、)で示される目的のスルホン
体を製造する方法である。D method (b) (■) (in the formula, X,
Y, R' and R'' have the same meaning as general formula (1) +7).) That is, β-turcapto- represented by general formula (IV)
This is a method for producing the desired sulfone compound represented by the general formula (V) by oxidizing an α-7 minoethylphosphonic acid fatty conductor with an oxidizing agent in a suitable solvent.
この反応はスルフィド体を酸化してスルホン体を製造す
る公知の方法を応用し実施される。This reaction is carried out by applying a known method for producing a sulfone compound by oxidizing a sulfide compound.
代表的な製造法は酸化剤として30%過酸化水素水を使
用し、水、にN−塩酸又は酢酸溶媒中で行う方法である
[ L、Goodman、 L、 O,Rose。A typical production method is to use 30% hydrogen peroxide as an oxidizing agent and conduct the process in water, N-hydrochloric acid, or acetic acid [L, Goodman, L, O, Rose.
B、 R,Baker、 J、 Org、Chew 2
3 /λJ−/ (/汀?)〕圓法
(X) (M) (XI)(式中、X
%YおよびR/は一般式(1)のそれと同じ意味を有す
。但しR′が水素原子の場合を含まな込)
すなわち、一般式(X)で示されるβ−メルカプトアミ
ノエチルホスホンI!!!誘導体を一般式(XI)で示
されるアルコールと縮合反応させ一般式(M)で示され
る目的のエステル体を製造する方法である。B, R, Baker, J, Org, Chew 2
3 /λJ-/ (/汀?)〕Enpo (X) (M) (XI) (wherein, X
%Y and R/ have the same meaning as in general formula (1). (However, this includes the case where R' is a hydrogen atom) In other words, β-mercaptoaminoethylphosphone I! represented by the general formula (X)! ! ! In this method, a derivative is subjected to a condensation reaction with an alcohol represented by general formula (XI) to produce a target ester represented by general formula (M).
この反応の代表例として縮合剤としてトリクロロアセト
ニトリルを使用する公知のエステル化法が挙げられる(
J、Szewczyk、 O,Wasia4−ewa
ki、Po1ioh J、Ohem !! /り/1
(/917))。A typical example of this reaction is the known esterification method that uses trichloroacetonitrile as a condensing agent (
J, Szewczyk, O, Wasia4-ewa
ki, Po1ioh J, Ohem! ! /ri/1
(/917)).
縮合反応は縮合剤としてトリクロロアセトニトリルを使
用し、ピリジンの存在下加熱することにより好都合に実
〃Iされる。The condensation reaction is conveniently carried out by heating in the presence of pyridine using trichloroacetonitrile as the condensing agent.
F法(脱保護反応)
(式中、n、X、Y、R’およびR2は前記一般式(I
)と同じ意味を有する。但しY1部およびR2が水素原
子である場合を含まない)すなわち一般式(1)で示さ
れるβ−メルカプト−α−アミノエチルホスホン酸誘導
体を脱保護する方法である。F method (deprotection reaction) (where n, X, Y, R' and R2 are represented by the above general formula (I
) has the same meaning as However, this method does not include the case where Y1 moiety and R2 are hydrogen atoms), that is, it is a method of deprotecting the β-mercapto-α-aminoethylphosphonic acid derivative represented by the general formula (1).
脱保護反応は公知の方法を応用して5A施される。通常
のペプチド化学およびホスホン酸化学の分野で用いられ
る当該保設基の除去に通した方法が適宜目的に添って選
択され実施式れる。The deprotection reaction is performed by applying a known method to 5A. Methods for removing the reserved groups used in the conventional fields of peptide chemistry and phosphonate chemistry are selected and carried out as appropriate depending on the purpose.
脱保護反応の代表例を例示すると
a)反応の場合、LlBrとピリジンと共に加熱する[
、T、 Eigewczyk、 a、Wasiele
waki。Typical examples of deprotection reactions are a) In the case of reaction, heating with LlBr and pyridine [
, T. Eigewczyk, a. Wasiele
waki.
Po1iah、 、T、 Ohem、 !z /
り11’ (/9t/) ) 、 又は水酸化す)
IJウムと処理する等の方法が挙げられる。Po1iah, ,T, Ohem, ! z/
11' (/9t/)) or hydroxide)
Examples of methods include treatment with IJum.
b)反応の場合、トリフロロ酢酸と加温、又は飽和美化
水素酸−酢酸七罠温で短時間処理する等の方法が挙げら
れる。In the case of b) reaction, methods include heating with trifluoroacetic acid, or short-time treatment with saturated beautified hydrochloric acid-acetic acid at 7-trap temperature.
C)およびd)反応の場合、飽和臭化水素酸−酢酸と加
温、又は濃塩酸と長時間加熱する等の方法が挙げられる
。In the case of C) and d) reactions, methods include heating with saturated hydrobromic acid and acetic acid, or heating with concentrated hydrochloric acid for a long time.
得られる目的の化合物がアミンの鉱酸若しくは有機酸塩
である場合、所望によシ、分子内塩に導かれる。代表例
を示すと、アミンが塩酸塩若しくは臭化水素酸塩である
場合、酸化プロピレンと処理する事により好都合に分子
内塩に導かれる。When the desired compound to be obtained is a mineral acid or organic acid salt of an amine, it is converted into an inner salt, if desired. As a representative example, when the amine is a hydrochloride or hydrobromide salt, treatment with propylene oxide conveniently leads to the inner salt.
A乃至F法の実施において製造される目的物の分離、精
製は何等格別の方法を用いる必要はなく、かかる目的の
為に通常用いられる周知の手段、例えば溶媒抽出、洗浄
、結晶化、イオン交換樹脂、順相および逆相カラムクロ
マトグラフィー寺により容易に目的を達成する事が出来
る。There is no need to use any special method for separating and purifying the target products produced in the implementation of Methods A to F, and well-known means commonly used for such purposes, such as solvent extraction, washing, crystallization, and ion exchange, can be used. The objective can be easily achieved using resin, normal phase and reverse phase column chromatography.
(実施例)
以下に実施例を示し、本発明を更に詳細に説明するが、
本発明は、その要旨を越えない限シ以下の実施例によっ
て限定されるものではない。(Example) The present invention will be explained in more detail by showing examples below.
The present invention is not limited to the following examples unless it exceeds the gist thereof.
実施例/
l−カルボベンゾキシアミノ−ツーメチルチオエチルホ
スホン酸S−オキシド
a)/−アミノーツーメチルチオエチルホスホン酸り、
ooy(jコ、6ミリモル)を炭酸水素ナトリウム−/
、I Jl (240ミリモル)の水溶液(ioo*)
に溶かし、エーテル−〇−を加えて、水冷撹拌下カルボ
ペンゾキシクロリドノ0.9m(j♂譲ミリモル)のエ
ーテル溶液(/J−tld)を30分で滴下し、さらに
水冷下3時間撹拌する。反応後エーテル層を除き、水層
なエーテルで洗浄し、氷冷下、41JHOJ−を加えて
酸性にし、酢酸エチルで抽出、飽和食塩水で洗浄、硫酸
マグネジタムで乾燥し、溶媒を減圧留去する。残渣をエ
ーテルから結晶とし/−力ルボベンゾキシアミノーーー
メチルチオエチルホスホン酸ホヌホンーへj J Jl
l (1,00ミリモル)をIOえて1時間撹拌する。Example / l-carbobenzoxyamino-twomethylthioethylphosphonic acid S-oxide a)/-aminotwomethylthioethylphosphonic acid,
ooy (j, 6 mmol) in sodium bicarbonate -/
, I Jl (240 mmol) in water (ioo*)
0.9 m (J♂yield mmol) of carbopenzoxychloride in ether solution (/J-tld) was added dropwise over 30 minutes with stirring under water cooling, and the mixture was further cooled for 3 hours under water cooling. Stir. After the reaction, remove the ether layer, wash with aqueous ether, make acidic by adding 41JHOJ- under ice cooling, extract with ethyl acetate, wash with saturated brine, dry over magnesium sulfate, and remove the solvent under reduced pressure. . The residue was crystallized from ether and converted into methylthioethylphosphonic acid.
Add IO (1,00 mmol) and stir for 1 hour.
析出する結晶をP去し、P#を減圧留去する。残渣を逆
相シリカゲルカラムクロマトグラフィー(’lio展開
溶媒θ〜10チメタノール含有水)で精製し表記の化合
物/、//I(収率6?%)を得る。The precipitated crystals are removed from P#, and P# is distilled off under reduced pressure. The residue was purified by reverse-phase silica gel column chromatography ('lio developing solvent θ to 10 timetanol-containing water) to obtain the indicated compounds /, //I (yield: 6%).
NMR(CD、OD、δ)−06θ、 2.70 (3
H,5xJCB、130−)、 j、/ 〜j、7 (
2H,m、 80H,−)、 u、0〜Q、7 (/
H,m、 80H20H−)、 j、06(2に、 B
、 −OH,Ph)。NMR (CD, OD, δ)-06θ, 2.70 (3
H, 5xJCB, 130-), j, / ~j, 7 (
2H, m, 80H, -), u, 0~Q, 7 (/
H, m, 80H20H-), j, 06 (2, B
, -OH, Ph).
70.26(jH,B、 Ph−)
実施例λ
/−アミノ−λ−メチルチオエチルホスホン酸S−オキ
シゼ
/−カルポベンゾキシアミノ−一−メチルチオエチルホ
スホ/酸8−オキシド/、//11(J、4t!ミリモ
ル)をトリフルオロ酸1111//ldに溶かし4to
℃でコ時間撹拌した後、エーテル/10y11を加え析
出する結晶をP取する。これをj%塩酸に溶かして数回
共沸し、残渣(1−[02塩)をエタノールに溶かし、
酸化プロピレンを加えて析出する結晶を戸数する、水−
エタノールに不溶の物質を戸去した後、F液を減圧留去
する。残渣をエーテルで粉末化すると表記の化合物3J
jW(収率ハ1)をジアステレオマーのl二lの混合物
として得る。融点/3θ〜/Jr”CC分解)
工R(KBr、 cm−’ ) /l/J’ 、 /
630 、10100ON (D、O,Na0Dδ)2
.7θ、 2.76 (3H,BX2 Cq、80−
)、 J、7〜!、! (jJ m、 EIOH,OH
−)実施例3
/−カルボベンゾキシアミノ−λ−エチルチオエチルホ
スホン#S−オキシド
a)/−アミノ−λ−エチルチオエチルホスホン酸λ、
j09 (/ 3.jミリモル)から*適例/a)と同
様にして/−カルボベンゾキシアミノーコーエチルテオ
エチルホスホン#J、−2gF(収率7!%)を得る。70.26 (jH, B, Ph-) Example λ /-amino-λ-methylthioethylphosphonic acid S-oxyze/-carpobenzoxyamino-1-methylthioethylphospho/acid 8-oxide/, //11 ( J, 4t! mmol) dissolved in trifluoroic acid 1111//ld, 4to
After stirring at °C for an hour, ether/10y11 was added and the precipitated crystals were collected. This was dissolved in j% hydrochloric acid and azeotroped several times, and the residue (1-[02 salt) was dissolved in ethanol.
Add propylene oxide and remove the crystals that precipitate.
After removing the substances insoluble in ethanol, liquid F is distilled off under reduced pressure. When the residue is powdered with ether, the indicated compound 3J is obtained.
jW (yield: 1) is obtained as a mixture of diastereomers. Melting point/3θ~/Jr"CC decomposition) Engineering R (KBr, cm-') /l/J', /
630, 10100ON (D, O, Na0Dδ)2
.. 7θ, 2.76 (3H, BX2 Cq, 80-
), J, 7~! ,! (jJ m, EIOH, OH
-) Example 3 /-carbobenzoxyamino-λ-ethylthioethylphosphone #S-oxide a)/-amino-λ-ethylthioethylphosphonic acid λ,
From j09 (/3.j mmol), /-carbobenzoxyamino-coethyltheoethylphosphone #J, -2gF (yield 7!%) is obtained in the same manner as in *Example/a).
b)/−カルボペンゾキシアミノーーーエチルチオエチ
ルホスホン酸4/6〜(/、23ミリモル)から実施例
/b)と同様にして表記の化合物200■を定量的に得
る。b) From /-carbopenzoxyamino-ethylthioethylphosphonic acid 4/6~(/, 23 mmol), the title compound 200<i>I is quantitatively obtained in the same manner as in Example/b).
実施例弘
/−アミノ−λ−エチルチオエチルホスホン酸B−オキ
シド
/−カルボベンゾキシアミノーコーエチルチオエチルホ
スホン!2日−オキシド700岬(i、?3ミリモル)
から実施例λと同様にして表記の化合物rjMf(収率
λ2%)をジアステレオマーの/二/の混合物として得
る。融点/ご!〜770℃(分解)
工R(KBr、 cm−’ ) 1531. /14
40. 101O101ON、O,δ)/、2J、/、
30 (JH,tXJ、J=+7、jHz、 OH,O
R,80−) 2.λ〜a、z (tll、 m。Example Hiroshi/-Amino-λ-ethylthioethylphosphonic acid B-oxide/-carbobenzoxyamino-coethylthioethylphosphone! 2 days - 700 capes of oxide (i, ?3 mmol)
In the same manner as in Example λ, the indicated compound rjMf (yield λ2%) is obtained as a mixture of /2/ diastereomers. Melting point/go! ~770°C (decomposition) Engineering R (KBr, cm-') 1531. /14
40. 101O101ON, O, δ)/, 2J, /,
30 (JH, tXJ, J=+7, jHz, OH, O
R, 80-) 2. λ~a,z (tll, m.
saシ0)I−、−(!馬5O−)
実施例!
/−アミノ−λ−メチルチオエテルホスホン酸S−ジオ
キシド
/−アミノーコーメチルチオエチルホスホン酸9.00
mg(r、2rミリモル)を酢rIk30−に溶かし、
10℃で30−過酸化水素水を7時間にμ―ずつ−6−
加える。室温で一晩放1jit後溶媒を減圧留去し、残
渣を水より再結晶して表記の化合物?’13■(収率/
r%)を得る。融点−弘♂〜2よ/ ”C(分解)
工R(KBr、 cM−’ )、At♂z、 /!2
0. /300゜//3j
NMR(D、O,Na0D、 δ) 3.26 (j
J B、 C旦、5o−)。sashi0)I-,-(!horse5O-) Example! /-amino-λ-methylthioethylphosphonic acid S-dioxide/-amino-comethylthioethylphosphonic acid 9.00
mg (r, 2r mmol) dissolved in vinegar rIk30-,
30-Hydrogen peroxide solution at 10℃ for 7 hours by μ-6-
Add. After standing overnight at room temperature, the solvent was distilled off under reduced pressure, and the residue was recrystallized from water to obtain the indicated compound. '13■ (yield/
r%). Melting point - Hiro♂~2yo/"C (decomposition) Engineering R (KBr, cM-'), At♂z, /!2
0. /300゜//3j NMR (D, O, Na0D, δ) 3.26 (j
JB, Cdan, 5o-).
LJ 〜4t、0 (JH,m、 8(3H,(4−
)実施例6
/−アミノーコーエチルチオエチルホスホン飯S−ジオ
キシド
/−アミノーコーエチルチオエテルホスホン酸Z♂/キ
(2,64tミリモル)から実施例!と同様にして、表
記の化合物3り/岬(収率6♂チ)を得る。融点2−〇
〜22Jr″C(分′s)工R(KBr、 cm−’
) /6/r、 /j30. /、!00−//3
O
NMR(D20.Na0D δ)j、j 〜j、タ
(j kia mlS C!!、 O旦−)、3.4
tO(,2kI、q、J−7,tHz。LJ ~4t, 0 (JH, m, 8(3H, (4-
) Example 6 Example from /-amino-coethylthioethylphosphonic acid S-dioxide/-amino-coethylthioethylphosphonic acid Z♂/ki (2,64t mmol)! In the same manner as above, the indicated compound 3/Misaki (yield: 6♂) was obtained. Melting point 2-〇~22Jr″C(min's)WorkR(KBr, cm-'
) /6/r, /j30. /,! 00-//3
O NMR (D20.Na0D δ)j, j ~j, Ta
(j kia mlSC!!, Odan-), 3.4
tO(,2kI,q,J-7,tHz.
−so、−ap、aa、) 、 7.4tθ(jH,t
、 1w7.jHz。-so, -ap, aa, ), 7.4tθ(jH,t
, 1w7. jHz.
−802−0)1.0旦、〕
実施例2
/−カルポペンゾキシアミノーツーメチルチオエチルホ
ヌホン酸モノエチルエステル/−カルポベンゾキシアミ
ノ−一一メチルチオエチルホヌホン酸コ、?71(り、
72ミリモル)Kmmビピリジン3θハトリクロロアセ
トニトリル!、/d(30ミリモル)および無水エタノ
ール八7d(j Oミリモル)を加え、100℃で3時
間撹拌する。-802-0) 1.0 days,] Example 2 /-carpobenzoxyamino-2-methylthioethylhonufonic acid monoethyl ester/-carpobenzoxyamino-11-methylthioethylhonufonic acid, ? 71(ri,
72 mmol) Kmm bipyridine 3θ Hatrichloroacetonitrile! , /d (30 mmol) and absolute ethanol 87d (j O mmol) are added and stirred at 100° C. for 3 hours.
溶媒を減圧留去し、残渣を飽和炭酸水素ナトリウム水溶
液に溶かし、酢酸エチルで洗浄する〇水層を冷却し、塩
酸を加えて酸性にし、酢酸エチルで抽出、飽和食塩水で
洗浄、硫酸す) IJウムで乾燥し、溶媒を留去する。Distill the solvent under reduced pressure, dissolve the residue in saturated aqueous sodium bicarbonate solution, and wash with ethyl acetate. Cool the aqueous layer, make it acidic by adding hydrochloric acid, extract with ethyl acetate, wash with saturated brine, and wash with sulfuric acid). Dry with IJum and evaporate the solvent.
残渣を酢酸エチルより再結晶し表記の化合物コ、t3p
c収率71%)を得る。融点107J 〜107.j℃
N M R(CD、OD、δ)八2j(3H,q、 、
T−7,OH2゜aH,c旦3)、2,0j(3■、
a、 O!!3B−)、 2i〜!、0(2L m、
5OH2−)、 a、r N4t、j(3)1. m、
80H,O旦−1−〇ジah、 )e s、or (
,2)1. s、 c告Ph ) 、 ?、、l (z
H。The residue was recrystallized from ethyl acetate to give the indicated compound, t3p.
(yield 71%). Melting point 107J ~ 107. j℃
N M R (CD, OD, δ) 82j (3H, q, ,
T-7,OH2゜aH,cdan3),2,0j(3■,
a, O! ! 3B-), 2i~! ,0(2L m,
5OH2-), a, r N4t, j (3) 1. m,
80H, Odan-1-〇jiah, )es, or (
,2)1. s, c complaint Ph), ? ,,l (z
H.
s、Ph−)
実施例?
/−アミノーコーメチルチオエチルホスホン酸モノエチ
ルエステル
/−力ルボペンゾキシアミノーコーメチルチオエチルホ
スホン酸モノエチルエステル600■(/、rOミリそ
ル)を臭化水素飽和酢酸溶液t*に1かし、2分後、エ
ーテルto−を添加して析出する納置を戸数する。得ら
れる結晶(HBr ’r4 )をエタノールに皺かし、
酸化グロレンを加える。溶媒を留去し、残渣を逆相シリ
カゲルカラムクロマトグラフィー(C1,展開溶媒0〜
70%メタノール含有水)で精製し、エタノールと酢酸
エチルよシ再結晶・すると表記の化合物、2/7tII
f(収率67%)を得る。融点/9り、!〜200J”
C(分解)
工R(KBr、 yB−” ) /64tO,/j%J
N MR(CD、OD、δ) i、、2z(3H,t、
!−7Hz。s, Ph-) Example? /-Amino-co-methylthioethylphosphonic acid monoethyl ester/-600 μl (/, rO millisol) of Rubopenzoxyamino-co-methylthioethylphosphonic acid monoethyl ester in 1 t* of hydrogen bromide saturated acetic acid solution After 2 minutes, add ether and let it precipitate. The obtained crystals (HBr'r4) were crushed in ethanol,
Add glolene oxide. The solvent was distilled off, and the residue was subjected to reverse phase silica gel column chromatography (C1, developing solvent 0 to
Purify with 70% methanol-containing water) and recrystallize from ethanol and ethyl acetate.Then, the indicated compound, 2/7tII
f (yield 67%). Melting point/9ri! ~200J”
C (decomposition) Engineering R (KBr, yB-”) /64tO, /j%J
N MR (CD, OD, δ) i,, 2z (3H, t,
! -7Hz.
−a)I、a!!、 )、 2./ 0 (jJ 8.
O上、S−)、 2.J 〜j、!(3H,m、 8
0H,OR−)、 j、7〜4<0.2(2kl、 m
。-a) I, a! ! , ), 2. / 0 (jJ 8.
O above, S-), 2. J~j,! (3H, m, 8
0H,OR-), j, 7~4<0.2(2kl, m
.
−0H20H,)
実施例り
/−力ルボベンゾキシアミノーーーエチルチオエチルホ
スホン酸モノエチルエステル/−カルボペンゾキシアξ
ノーコーエチルチオエチルホスホン酸J、2e # (
10,/ミリモル)から実施例2と同様にして表記の化
合物λ、jOI(収率2/%)を得る。融点10/〜1
0λ℃NMR(OD、OD、δ) /、20(J’Ji
、 t、 :J−7,jHz80H,0旦3 )、 /
、Jj (jH,t、 J m7H2,OCR,OB、
)。-0H20H,) Example /-Carbobenzoxiamino-Ethylthioethylphosphonic acid monoethyl ester/-Carbopenzoxia ξ
Norcoethylthioethylphosphonic acid J, 2e # (
10,/mmol) to obtain the indicated compound λ, jOI (yield 2/%) in the same manner as in Example 2. Melting point 10/~1
0λ℃NMR (OD, OD, δ) /, 20 (J'Ji
, t, :J-7,jHz80H,0dan3), /
, Jj (jH,t, J m7H2,OCR,OB,
).
、2.jj(,2H,q、 J−7,!Kg、 BOシ
0−)コ、7〜j、/(,2H,m、 80H,−)、
!、/〜4を譲(JH,m。, 2. jj(,2H,q, J-7,!Kg, BOshi0-)ko, 7~j, /(,2H,m, 80H,-),
! , /~4 transfer (JH, m.
BOHloH,−屯oaジOH,) J−0/ 0 (
λH,s、 −0R1Ph)。BOHloH, -tunoajiOH,) J-0/0 (
λH,s, -0R1Ph).
2.30(jH,s、 Ph−)
実施例IO
/−アミノーコーエチルチオエチルホヌホン酸モノエチ
ルエステル
/−カルボベンゾキシアミノーーーエチルチオエチルホ
スホン酸モノエチルエステル/0.20p (i3ごミ
リモル)から実施例♂と同様にして表記の化合物60−
岬(収率r−一)を得る。2.30 (jH, s, Ph-) Example IO /-amino-coethylthioethylhonufonic acid monoethyl ester/-carbobenzoxyamino-ethylthioethylphosphonic acid monoethyl ester/0.20p (i3 (mmol) to the indicated compound 60- in the same manner as in Example ♂.
A cape (yield r-1) is obtained.
融点/りO〜/り2℃
工R(KBr、 cm−’ ) /43θ、 /J’
4tONMR(CD、OD、δ) /、21 (JH,
t、 Jl+lI7.JH2゜80H,OH,)、 7
.30 (jH,t、 ;J−7,OEM。Melting point / 0 ~ / 2℃ R (KBr, cm-') /43θ, /J'
4tONMR (CD, OD, δ) /, 21 (JH,
t, Jl+lI7. JH2゜80H,OH,), 7
.. 30 (jH,t, ;J-7, OEM.
ooa、o鵬)t 2,4tj (Jl(、q、、7m
7.jug。ooa, o peng)t 2,4tj (Jl(,q,,7m
7. jug.
日Op、OH,)、 、2.♂〜 jo、t (J
R,m、SO馬C!!−)。Day Op, OH,), ,2. ♂~ jo, t (J
R, m, SO horse C! ! -).
J、l 〜g、j (λH,m、0OHffiOH8)
実施例//
/−アミノーコーメチルチオエチルホスホン酸モノエチ
ルエステルS−ジオキシド
/−アミノーコーメチルチオエチルホスホン酸モノエチ
ルエステル4tr21tq(λ、4を一ミリモル)を実
施例!と同様に反応させ溶媒な留去後、逆相シリカゲル
カラムクロマトグラフィー(’11;展開溶媒、水)で
精製し、メタノールよシ再結晶し表記の化合物j3.2
岬(収率り1%)を得る。融点コ/r−コ/り℃(分解
)
工R(KBr、 cIn−’ ) /62j、 /j
41θ、 /300゜/ /4tO
NMR(D、O,a ) /、2J−(JH、t、 J
sw7Hz。J, l ~ g, j (λH, m, 0OHffiOH8)
Example // /-Amino-co-methylthioethylphosphonic acid monoethyl ester S-dioxide/-Amino-co-methylthioethylphosphonic acid monoethyl ester 4tr21tq (λ, 1 mmol of 4) Example! After reacting in the same manner as above and distilling off the solvent, it was purified by reverse-phase silica gel column chromatography ('11; developing solvent, water), and recrystallized from methanol to obtain the indicated compound j3.2.
A cape (yield 1%) is obtained. Melting point co/r-co/ri℃ (decomposition) Engineering R (KBr, cIn-') /62j, /j
41θ, /300°/ /4tO NMR (D, O, a) /, 2J-(JH, t, J
sw7Hz.
OH,0H8)、 3.20 (、?H,51,OH,
SO,−)、 j、4−1.7(J−H,m、 B−0
1j、OH−)、 −OH,CH,)実施例/2
1−アミノーコーエチルチオエチルホスホン酸モノエチ
ルエステル日−ジオキシド
/−アミノーコーエチルチオエチルホスホン酸モノエチ
ルエステル4tOO岬(i、trミリモル)から実施例
//と同様にして表記の化0合物λりθ1q(収率ぶ3
%)を得る。融点コO♂〜、2//’C(分解)
工R(KBr、 z−’−) /620. /141
0. /301゜//4tO
MMR(D、O,δ) /、Jj(jilt、 t、
J履4.1HIM。OH,0H8), 3.20 (,?H,51,OH,
SO, -), j, 4-1.7 (J-H, m, B-0
1j, OH-), -OH,CH,) Example/2 1-amino-coethylthioethylphosphonic acid monoethyl ester -dioxide/-amino-coethylthioethylphosphonic acid monoethyl ester 4tOO Misaki (i, tr mmol) to the compound λ θ1q (yield 3
%). Melting point KO♂~, 2//'C (decomposition) Engineering R (KBr, z-'-) /620. /141
0. /301°//4tO MMR (D, O, δ) /, Jj (jilt, t,
J shoes 4.1HIM.
00H!O旦、 )、 /、Jj (Jll、 t、
J−7,1Hz。00H! Odan, ), /, Jj (Jll, t,
J-7, 1Hz.
−so、−on、○L’s )e ’−J j (”e
qe J−7,! Hg。-so, -on,○L's )e '-J j ("e
qe J-7,! Hg.
80、OH,OR,)、 LJ 〜41.3 (jll
、 m、 Bog、(4−。80, OH, OR,), LJ ~41.3 (jll
, m, Bog, (4-.
oa4.am、 )
実施例/jj
/−アミノ−λ−(/′−メチルテトラゾールー!′−
イル)チオエチルホスホン酸ジエチルエステル
ーーアジリジニルホスホン酸ジエチルエステル≦4t0
119(3,j♂ミリモル)および/−メチル−!−メ
ルカプトテトラゾール730■(7,7jミリモル)を
クロロホルム/3tnlに溶かし三フフ化ホウ素ジエチ
ルエーテルm体0./dを加え、室温で3日間撹拌する
。反応後、飽和炭酸水素ナトリウム水溶液を加え、クロ
ロホルムで抽出し、抽出液を飽和食塩水で洗浄、硫酸マ
グネシウムで乾燥し、溶媒を減圧留去する、残渣をシリ
カゲルカラムクロマトグラフィー(展開溶媒1.3%メ
タノール含有クロロホルム)で精製すると表記の化合物
710■(収″4≦7%)を得る。oa4. am, ) Example/jj /-amino-λ-(/'-methyltetrazole-!'-
yl) Thioethylphosphonic acid diethyl ester - aziridinylphosphonic acid diethyl ester ≦4t0
119 (3,j♂mmol) and/-methyl-! -Mercaptotetrazole 730 mmol (7.7 mmol) was dissolved in chloroform/3 tnl and boron trifufluoride diethyl ether m form 0. /d and stir at room temperature for 3 days. After the reaction, a saturated aqueous sodium bicarbonate solution was added and extracted with chloroform. The extract was washed with saturated brine, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (developing solvent 1.3 % methanol in chloroform) to give the title compound 710 (yield 4≦7%).
工R(neat、am−リ /42j
NMR(CD0I、、 δ)/、J7 (4H,t、
J+m7Hz。Engineering R (neat, am-ri /42j NMR (CD0I,, δ) /, J7 (4H, t,
J+m7Hz.
OH2(Ii、)、/、71 (2H,s、−NH,)
、J、Oj〜j、り!(j ji# m# 日on
、c!!−)、 3.りJ (jH,s、No!3)
。OH2(Ii,),/,71 (2H,s,-NH,)
, J, Oj~j, Ri! (j ji# m# day on
,c! ! -), 3. RiJ (jH, s, No! 3)
.
+1.JO(uki、 q 、 tl J−7Hz、
7Hz、 −0!!tOH,)実施例/4t
l−アミンーーー(/′−メチルテトラゾールー114
ル)チオエチルホスホン酸
/−アミノ−!−(/’−メチルテトラゾール+ j’
−イル)チオエチルホスホン酸ジエチルエステル710
119(コ、4t/ミリモル)を臭化水素飽和酢戯溶液
、20M1に溶かし室温でグ時間、J−1℃で30分間
撹拌する。反応液を室温に冷却し、エーテル200−を
加え析出する沈澱を冷却(0℃)、F取し、エーテルで
洗浄する。+1. JO (uki, q, tl J-7Hz,
7Hz, -0! ! tOH,) Example/4t l-amine-(/'-methyltetrazole-114
) thioethylphosphonic acid/-amino-! -(/'-methyltetrazole + j'
-yl)thioethylphosphonic acid diethyl ester 710
119 (4 t/mmol) was dissolved in a 20 M1 hydrogen bromide saturated vinegar solution and stirred at room temperature for 3 hours and at J-1°C for 30 minutes. The reaction solution was cooled to room temperature, ether 200°C was added, and the precipitate formed was cooled (0°C), filtered, and washed with ether.
得られる沈澱(HBr塩)をエタノール21dに溶かし
酸化プロピレン7dを加え室温で7時間撹拌し0℃に冷
却する。析出する結晶をVS取、エタノールおよびエー
テルで洗浄すると表記の化合物りj OIIF(収率7
.tl)を得る。融点203〜−oa”cc分解)
工R(KBr、 eM−” ) /6.lr、 /j1
0. /jJjHMR(DtO,Na0D ) 3.3
0−44.10 (jH,m、α。The resulting precipitate (HBr salt) was dissolved in 21 d of ethanol, 7 d of propylene oxide was added, and the mixture was stirred at room temperature for 7 hours and cooled to 0°C. When the precipitated crystals were collected with VS and washed with ethanol and ether, the indicated compound was obtained (yield: 7
.. tl) is obtained. Melting point 203~-oa"cc decomposition) Engineering R (KBr, eM-") /6. lr, /j1
0. /jJjHMR(DtO,Na0D) 3.3
0-44.10 (jH, m, α.
β−C旦Cシー)、 4t、02 (j[、8,N−0
)13)実施例/!
/−カルボベンゾキシアミノ−λ−(7/−メチルテト
ラゾール−61、(ル)チオエチルホスホン酸
/−アミノ−λ−(/′−メチルテトラゾールー!′−
イル)チオエチルホスホンj!Iλ/θ■(/、/7ミ
リモル)を炭ば水素ナトリウム34401q(ダ、/ミ
リモル)の水溶液(/ j@/)に浴かし、カルボベン
ゾキシクロリド−4o IIF(へj2ミリモル)のエ
ーテル溶液(10gd)を滴下し、室温で1時間撹拌す
る。以後実施例/ a)と同様に処理しく但しエーテル
からの結晶化は省111i!))表記の化合物コ♂Oq
(収率、(4tチ)を得る。β-CdanCcy), 4t, 02 (j[, 8, N-0
)13) Example/! /-carbobenzoxyamino-λ-(7/-methyltetrazole-61, (l)thioethylphosphonic acid/-amino-λ-(/'-methyltetrazole-!'-
il) thioethylphosphophone j! Iλ/θ■ (/, /7 mmol) was bathed in an aqueous solution (/j@/) of sodium carbonate 34401q (da,/mmol), and ether of carbobenzoxy chloride-4o IIF (hej2 mmol) was added. Add solution (10 gd) dropwise and stir at room temperature for 1 hour. Thereafter, the process was carried out in the same manner as in Example/a) except that the crystallization from ether was omitted. )) The indicated compound ♂Oq
(Yield, (4t) is obtained.
実施例7g
/−カルボベンゾキシアミノ−2−(//−メチルテト
ラゾール−!′−イル)チオエチルホスホン酸モノエチ
ルエステル
/−カルボベンゾキシアはノーJ −(/’−メチルテ
トラゾールー!′−イル)チオエチルホスホン#!2♂
0q(0,7!ミリモル)、無水ピリジンjm、)リク
ロロア七トニトリル32!岬(J、27ミリモル)およ
び無水エタノール70り岬(,2,Jj j 17モル
)を用い、実施例7と同様にして表記の化合物コク0岬
(収*り0チ)を得る。Example 7g /-carbobenzoxyamino-2-(//-methyltetrazol-!'-yl)thioethylphosphonic acid monoethyl ester/-carbobenzoxyamino-2-(//-methyltetrazol-!'-yl) -yl)thioethylphosphophone #! 2♂
0q (0,7! mmol), anhydrous pyridine jm,)lichloroa heptonitrile 32! Using Misaki (J, 27 mmol) and 70 mol of absolute ethanol (,2, Jj j 17 mol), the described compound Misaki (Yield: 0 Chi) is obtained in the same manner as in Example 7.
N MR(CDO4,、δ)/、/l (jH,t、
J−7Hz。N MR(CDO4,,δ)/,/l (jH,t,
J-7Hz.
OH,043)、 J’、/J’ 〜4t、7..2
(jH,m、 −8OW、OH−。OH, 043), J', /J' ~4t, 7. .. 2
(jH,m, -8OW,OH-.
−O馬OH,)、 3.73 (jH,+1. NO!
3)、 r、06 (JH。-O horse OH,), 3.73 (jH, +1. NO!
3), r, 06 (JH.
s、 −OH,PI)、 lh、jJ (jH,d、
ImrHz、 0OH3)。s, -OH, PI), lh, jJ (jH, d,
ImrHz, 0OH3).
7、.2J’(jH,s、 Ph)、 9.jO(/k
l、 s、 0IL)実施例/7
/−アミノーーー(/′−メチルテト2ゾール+ j/
−イル)チオエチルホスホン鍍モノエチルエステル
/−カルボペンゾキシアミノ−2御(7/−メチルテト
2ゾールー!′−イル)チオエチルホスホン酸そノエチ
ルエステルコ2oキ(o、62ミリモル)を臭化水素飽
和酢は溶液3dに浴かし、室温でt分間撹拌する。反応
液にエーテルio。7. 2J'(jH,s, Ph), 9. jO(/k
l, s, 0IL) Example/7 /-amino-(/'-methylteto2zole+j/
-yl)thioethylphosphonic acid monoethyl ester/-carbopenzoxyamino-2-(7/-methyltet2zol-!'-yl)thioethylphosphonic acid monoethyl ester (o, 62 mmol) Hydrogen bromide saturated vinegar is added to solution 3d and stirred for t minutes at room temperature. Add ether io to the reaction solution.
−を加え析出する沈皺を冷却(0℃)下戸城し、エーテ
ルで洗浄する。得られる沈設(HBr塩)をエタノール
/j−に溶かし、酸化プロピレンJゴを加える。溶媒を
減圧留去し、残渣をエーテルで洗浄すると表記の化合物
i 4to trq (収率2rチ)を得る。融点77
〜//!℃
工R(KBr、 cm−’ )/710. /4コj
、 /3IItONMR(D、O,Na0D、 δ
)/、20 (JH,t、 J−7Hz。- is added, and the precipitated wrinkles are cooled (0°C) and washed with ether. The resulting precipitate (HBr salt) is dissolved in ethanol/J- and propylene oxide J- is added. The solvent is distilled off under reduced pressure and the residue is washed with ether to obtain the title compound i 4to trq (yield: 2r). Melting point 77
~//! °C Engineering R (KBr, cm-')/710. /4koj
, /3IItONMR(D,O,Na0D, δ
)/, 20 (JH,t, J-7Hz.
OH,OH3)、 !、、2j 〜4t、Jj (jH
,m、 −8CH,OR−。OH, OH3), ! ,,2j ~4t, Jj (jH
,m, -8CH,OR-.
−OH,0H3)、 4t、θj (jH,B、 NO
H,)実施例/l
l−アミノーーーカルパモイルチオエチルホスホン酸
ホスホシスチンを水と濃[1!!(/二/v/v)の混
液ダθdK#かし、パラジウム黒20019を加えて室
温、常圧下、水素添加する。io待時間後媒をP去し、
p液を減圧乾固しホスホシスティン・塩酸塩を定量的(
790〜)に得る。-OH, 0H3), 4t, θj (jH, B, NO
H,) Example/l l-amino-carpamoylthioethylphosphonic acid phosphocystine was concentrated with water [1! ! (/2/v/v) of θdK# oak and palladium black 20019 were added to the mixture and hydrogenated at room temperature and normal pressure. io waiting time post-medium is removed,
The p solution was dried under reduced pressure to quantitatively extract phosphocystine hydrochloride (
790~).
これに水7.1−および酢酸θ、λ、2 fRt(L/
ミリそル)を加え、水冷下シアン酸カリウムにコθ■(
7,4jjHJモル)の水浴液(jrnl>を滴下する
。反応液を室温でダ日放置し、析出する結晶なPiする
と表記の化合物/joyq(収率20%)を得る。融点
24tr −26J℃(分解)工R(KBr、 cIn
−’ )/710. 11mり0. /jり0゜/!
36゜
実施例/9
/−アミノ−λ−フェニルカルバモイルチオエチルホス
ホン酸塩酸塩
ホスホシスチンtrr2q(コ、/4tミリモル)よシ
実施例//と同様に水素添加し、定量的に得られるホス
ホシスティン塩酸塩をジメチルホルムアミド!−に溶か
し、イソシアン酸フェニル0.24tlR/(≦、/−
ミリモル〕を加え室温でダ日間放直する。反応後溶媒を
減圧留去し、!!4渣を9よチエタノールから結晶させ
ると表記の化合物♂20■(収率4tt%)を得る。融
点/?!〜200℃(分解)
工R(KBr、 tB−’ ) /700. /61
0. /6θQ。To this, water 7.1- and acetic acid θ, λ, 2 fRt (L/
Add diluted sodium chloride (mirisol) and add θ■ (
A water bath solution (jrnl> of 7,4jjHJ mol) is added dropwise.The reaction solution is allowed to stand for a day at room temperature, and when the crystalline Pi precipitates, the indicated compound/joyq (yield 20%) is obtained.Melting point: 24tr - 26J℃ (Disassembly) Engineering R (KBr, cIn
-' )/710. 11m 0. /jri0゜/!
36゜Example/9 /-Amino-λ-phenylcarbamoylthioethylphosphonate hydrochloride Phosphocystine trr2q (co, /4t mmol) was hydrogenated in the same manner as in Example // and quantitatively obtained phosphocystine Dimethylformamide hydrochloride! -, phenyl isocyanate 0.24tlR/(≦,/-
mmol] and leave to stand at room temperature for 2 days. After the reaction, the solvent was distilled off under reduced pressure! ! The 4 residue is crystallized from 90% ethanol to obtain the title compound ♂20■ (yield: 4tt%). Melting point/? ! ~200℃ (decomposition) Engineering R (KBr, tB-') /700. /61
0. /6θQ.
/に13;、 /j0O
N M R(CI+!、Co、D、δ) j、7〜4t
J (j)1. m。/ to 13;, /j0O N M R (CI+!, Co, D, δ) j, 7~4t
J (j)1. m.
5O40旦−)、 7.0〜7.j (J−H,m、
Ph )実施例−〇
/−アミノーーーフェニルチオ力ルパモイルチオエチル
ホスホン酸
ホスホシスチンJ/、lq(/、00ミリモル)よシ実
施例/rと同様に水素添加し、定量的に得られるホスホ
システィン塩酸塩なジメチルホルムアミド7、tNtl
ll:溶かし、イソチオシアン酸フェニル0.2り、Z
(2,4tミリモル)t’加え室温で/j待時間つい
で60℃で!時間加熱する。5O40dan-), 7.0~7. j (J-H, m,
Ph) Example-〇/-amino-phenylthio-rupamoylthioethylphosphonic acid phosphocystine J/, lq (/, 00 mmol) was hydrogenated in the same manner as in Example/r and obtained quantitatively. Phosphocystine hydrochloride dimethylformamide 7, tNtl
ll: dissolved, phenyl isothiocyanate 0.2, Z
(2.4t mmol) t' added at room temperature/j waiting time then at 60℃! Heat for an hour.
反応後溶媒を減圧留去し、残渣(HCl塩)をメタノー
ルに溶かして酸化プロピレンを加え溶媒を留去する。残
渣を逆相シリカゲルカラムクロマトグラフィー(018
;展開溶ts、10〜−θチメタノール含有水)で精製
し、水より再結晶すると表記の化合物/?0岬(収率6
2%)を得る。融点−4t、<〜7℃(分解)
工R(KBr、 an−’ ) /1.00. /jコ
!、/!θQ。After the reaction, the solvent is distilled off under reduced pressure, the residue (HCl salt) is dissolved in methanol, propylene oxide is added, and the solvent is distilled off. The residue was subjected to reverse phase silica gel column chromatography (018
; developing solution ts, 10~-θ timethanol-containing water) and recrystallized from water, the indicated compound/? 0 cape (yield 6
2%). Melting point -4t, <~7°C (decomposition) Engineering R (KBr, an-') /1.00. /jko! ,/! θQ.
NMR(OF、CtO□D、δ) El 〜g、r (
jH,m。NMR (OF, CtO□D, δ) El ~g, r (
jH, m.
soシC旦−)、 7.31(jH,a、 Ph)実施
例2/
/−カルボベンゾキシアミノ−,2−(2’、3’−ジ
ヒドロキシグロビル)チオエテルホスホン酸ジエチルエ
ステル
N−カルボベンゾキシーコーアジリジニルホスホン酸シ
エチルエステルタ609(3,07ミリモル)およびα
−チオグリセリンタタ0■(り、−〇ミリモル)をクロ
ロホルムJ r *に溶かし、三フフ化ホウ素ジエチル
エーテル錯体0、/J−61を加え、室温でy日間撹拌
する。以後実施例/3と同様に処理(但しシリカゲルカ
ラムクロマトグラフィーの展開溶媒;4tチメタノエR
(neat、 5F+−’ ) /720. /おt
! 、 /141ONMR(CD0J、、 、δ) /
、J4t(jH,t、 Jm7k。7.31 (jH, a, Ph) Example 2/ /-Carbobenzoxyamino-,2-(2',3'-dihydroxyglobil)thioetherphosphonic acid diethyl ester N- Carbobenzoxy-coaziridinylphosphonic acid ethyl ester 609 (3,07 mmol) and α
-Thioglycerin tata (0, -0 mmol) is dissolved in chloroform Jr*, boron trifufluoride diethyl ether complex 0,/J-61 is added, and the mixture is stirred at room temperature for y days. Thereafter, the treatment was carried out in the same manner as in Example 3 (however, the developing solvent for silica gel column chromatography: 4t Timetanoe R)
(neat, 5F+-') /720. /Ot
! , /141ONMR(CD0J,, ,δ) /
, J4t(jH,t, Jm7k.
OH*O:、 ) /、30 (jH,t、 J=7f
lffi、 OH,O!!、)。OH*O:, ) /, 30 (jH,t, J=7f
lffi, OH, O! ! ,).
2.16〜ujj (/44 H,m、 −0R20H
(4,Son、0ff−。2.16~ujj (/44 H, m, -0R20H
(4, Son, 0ff-.
0!、0H3Xコ、 OHx、z)、 !、/J (2
H,a、 −0当Ph ) 。0! , 0H3X, OHx, z), ! , /J (2
H, a, -0 equivalent Ph).
z、70 (iH,a、 J−i2kLz、 0ONK
−)、 y、jO(sJs、Ph)
実施例2λ
/−アミノーコー(J/、 31−ジヒドロキシグロビ
ル)チオエチルホスホン酸
/−カルポベンゾキシアミノーーー(21,j/−シヒ
ドロキシグロビル)チオエチルホスホン酸ジエチルエス
テルJ−jOq(/、3/ ミIJモル)を黴塩i!i
7mK溶かし、77時間加熱還流する、溶媒を減圧留去
し、残渣にエタノールを加えて不溶の物質をP去し、F
液に酸化プロピレン!−を加える。θ’CK冷却し、析
出する結晶を戸数してエタノールおよびエーテルで洗浄
し逆相シリカゲルカラムクロマトグラフィー(O12;
展開溶媒水−メタノール)で精製すると表記の化合物9
owq(収率30%)を得る。融点/70〜/7.2.
j℃(分解)
工、R(KBr、 cm−’ ) /j/J、 /6
11N M R(DtO、Na0D 、δ)コ、70−
u、jO(cl’H,m。z, 70 (iH, a, J-i2kLz, 0ONK
-), y, jO (sJs, Ph) Example 2λ /-Aminocor(J/, 31-dihydroxyglobil)thioethylphosphonic acid/-Carpobenzoxyamino-(21,j/-dihydroxyglobil) Thioethylphosphonic acid diethyl ester J-jOq (/, 3/mi IJ mol) is mixed with mold salt i! i
Dissolved at 7 mK and heated under reflux for 77 hours. The solvent was distilled off under reduced pressure. Ethanol was added to the residue to remove insoluble substances, and F
Propylene oxide in liquid! Add -. θ'CK was cooled, the precipitated crystals were washed with ethanol and ether, and subjected to reverse phase silica gel column chromatography (O12;
When purified with developing solvent water-methanol), the indicated compound 9 is obtained.
owq (yield 30%) is obtained. Melting point /70~/7.2.
j℃(decomposition) , R(KBr, cm-' ) /j/J, /6
11N MR (DtO, Na0D, δ), 70-
u,jO(cl'H,m.
−ckl、a旦C馬SC旦、C旦−) 出 願 人 三シ化成工業株式会社 代 理 人 弁理士 長谷用 − ほか/名-ckl, adanCumaSCdan, Cdan-) Sender Sanshi Kasei Kogyo Co., Ltd. Representative Patent Attorney Hase - Others/names
Claims (1)
合を含まない。) を意味するか、又は b) ▲数式、化学式、表等があります▼ (式中、R^3は水素原子又はアルキル基を意味する。 ) を意味するか、又は c) ▲数式、化学式、表等があります▼ (式中Zは0又はS、R^4は水素原子、アルキル基又
はアリール基を意味する。但しn が1および2の場合を含まない。)を意味 する。Yは水素原子又はアミノ基の保護基 を、R^1およびR^2は同一あるいは相異なる水素原
子又はアルキル基を意味する〕 で示されるβ−メルカプト−α−アミノエチルホスホン
酸誘導体。(1) General formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) [In general formula (I), n means 0, 1 or 2, and X has a) substituent. It means a good alkyl group (however, this does not include the case where n is 0), or b) ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R^3 means a hydrogen atom or an alkyl group. ) or c) ▲Mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, Z means 0 or S, and R^4 means a hydrogen atom, an alkyl group, or an aryl group.However, when n is 1 or 2) does not include the case of ). Y is a hydrogen atom or a protecting group for an amino group, and R^1 and R^2 are the same or different hydrogen atoms or alkyl groups] A β-mercapto-α-aminoethylphosphonic acid derivative.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61056683A JPS62215597A (en) | 1986-03-14 | 1986-03-14 | Beta-mercapto-alpha-aminoethylphosphonic acid derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61056683A JPS62215597A (en) | 1986-03-14 | 1986-03-14 | Beta-mercapto-alpha-aminoethylphosphonic acid derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62215597A true JPS62215597A (en) | 1987-09-22 |
Family
ID=13034230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61056683A Pending JPS62215597A (en) | 1986-03-14 | 1986-03-14 | Beta-mercapto-alpha-aminoethylphosphonic acid derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62215597A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010014943A2 (en) * | 2008-08-01 | 2010-02-04 | Bioxiness Pharmaceutics, Inc. | Methionine analogs and methods of using same |
-
1986
- 1986-03-14 JP JP61056683A patent/JPS62215597A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010014943A2 (en) * | 2008-08-01 | 2010-02-04 | Bioxiness Pharmaceutics, Inc. | Methionine analogs and methods of using same |
WO2010014943A3 (en) * | 2008-08-01 | 2011-01-13 | Bioxiness Pharmaceutics, Inc. | Methionine analogs and methods of using same |
US8580859B2 (en) | 2008-08-01 | 2013-11-12 | Bioxiness Pharmaceuticals, Inc. | Methionine analogs and methods of using same |
US9695119B2 (en) | 2008-08-01 | 2017-07-04 | Bioxiness Pharmaceuticals, Inc. | Methionine analogs and methods of using same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7923558B2 (en) | Method for obtaining pure tetrahydrocannabinol | |
KR20050109633A (en) | A process for preparing 2-amino-1,3-propandiol derivatives | |
JPS62215597A (en) | Beta-mercapto-alpha-aminoethylphosphonic acid derivative | |
KR101269491B1 (en) | Preparation method for entecavir | |
US3868418A (en) | Novel N-(ortho- and para-nitrobenzoyl)-sulfoximine intermediates and process for their production | |
EP0490970B1 (en) | New route of synthesis for protected nitrogen mustard prodrugs | |
US2493090A (en) | Composition of matter | |
US6576764B2 (en) | Synthesis and crystallization of piperazine ring-containing compounds | |
US828846A (en) | Process of making alkamins. | |
US3551433A (en) | Preparation of 4-phenyl-4-acyloxypiperidine | |
US2927925A (en) | Scopine and sgopoline esters of alpha | |
US2655504A (en) | N, n-disubstituted aminoalkanol esters of alpha, alpha-diacyltoluic acids and their salts | |
US3751462A (en) | Process for preparation of substituted fluoromethanesulfonanilides | |
JP2007513134A (en) | Improved synthesis of 2-substituted adenosine | |
CN111253405B (en) | Preparation method of biapenem intermediate | |
WO1990015794A1 (en) | Novel stereoisomers | |
JPH0139420B2 (en) | ||
JPH0510354B2 (en) | ||
US2517496A (en) | Preparation of symmetrical monoaminodihydroxytoluene | |
JPS63270650A (en) | P-(trans-4-aminomethylcyclohexylcarbonyl) phenylpropionic acid | |
US3000922A (en) | Quaternary salts of chloramphenicol esters of amino acids | |
US2673879A (en) | Substituted haloalkylamines | |
CA1099719A (en) | Process for the preparation of n-(1-benzylpiperid-4- yl)-benzamides | |
US2582256A (en) | Esters of alpha-piperidino alpha cyclohexyl acetic acid and their production | |
IL25453A (en) | Process for the preparation of 2-amino-imidazoles |